HCB Chapter 586 Clinical Trial Press Conference
Chapter 586 Clinical Trial Press Conference
In the next few days, apart from personally directing a few trades in his foreign exchange studio in Xinrou Building, Ye Qiusheng basically spends time chatting with elders, relatives and younger brothers or visiting them. Of course, inspiring them to start their own businesses is also the answer. There is meaning.
These few times of personal trading increased his assets by more than 20 billion US dollars, and he earned back the investment of the three family entrepreneurial funds in a few days.
Similarly, Ye Hanyu has not been idle these days.
She took a few sisters and sisters-in-law to shop around, bought clothes, made spas, and dressed them up as wealthy ladies and rich wives. However, in addition to shopping, he also took the sisters-in-law to charity twice, I went to nursing homes and orphanages to condolences, and sent a lot of things out.
The eldest son Wang followed behind to serve, and he contributed money and effort, which surprised the girls of Ye and Zhao's family.
This is not like the legendary Mr. Wang!
To be honest, the scandal between Mr. Wang and Mrs. Ye has been flying all over the place during this period of time, and the stories of the two of them are everywhere on the Internet. The latest charity event was also a hot search, which really changed many people's perception of Mr. Wang. impression.
This can be regarded as one of his gains.
What I have to say is that when Ye Hanyu and Mr. Wang went to the orphanage to give condolences, Chairman Wang also appeared in the orphanage and had a good talk with Ye Hanyu, which caused a lot of speculation on the Internet. .
Some people say that the eldest son Wang changed his mind because he was rushing to get married.
Others said that Mr. Wang would not dare to play with Miss Ye family if he played with anyone.
Netizens thought it was right, and there were countless likes.
Anyone who is a person knows that a family that can donate 7 billion anonymously is not something the Wang family can afford.
For a time, words of blessing flooded the Internet.
Because Ye Hanyu has too many things to do and spends little time online, no one dared to tell her about the gossip on the Internet. More and more casual, as if they have become real friends.
Mr. Wang opened his mouth and shut his mouth and called "Xiaoyu Xiaoyu", but she also accepted it gladly and didn't take it as disobedience.
However, from now on, she really has no idea about that.
And Mr. Wang didn't dare to mention words like "love, liking, being friends" in front of her, and things were developing so strangely.
Concubine Yunye is in the office of a vice president of the Supreme Court
Under the urging, she finally received a reply, agreeing to her resignation, and she went to Xinrou Finance on the same day and officially took over the authority of Xinrou Finance.
With the participation of Concubine Yunye, the acquisition of "Kano Biology" progressed rapidly.
The asset appraisal and accounting and audit work have all come to an end, and the two parties are negotiating the terms of the acquisition contract based on this, and the acquisition work will be over in a few days.
Ye Qiusheng submitted an application to mss, requesting to help it find talents related to biological gene research, and the character and zz must be absolutely reliable.
Boss Chai attached great importance to this and assigned the task to Peng Xinghua.
President Wu also called Ye Qiusheng to inquire about precision-guided weapons for ground combat, and he took it seriously that day.
Ye Qiusheng promised to actively communicate with the monsters and try his best to meet their needs.
President Wu said that he would send someone to contact him.
Ye Qiusheng disagrees.
Then there is the daily customization news. Ye Qiusheng clicks on customization at different times and places. If all the search results are trivial, the host of the webpage is kind and will give them corresponding points every time.
In a blink of an eye, the time came to August 17th, and today is the day for the public experiment of Fengjing Shiji Yeli Pharmaceutical's "Cancer".
August 17 at 18:00 sharp.
The first press conference of the public clinical trial of Shiji Yeli cancer inhibitor was held in the banquet hall on the second floor of Fengjing Intercontinental Hotel.
Also attending the press conference were representatives from the two ministries and commissions of Huahuajia, the World Health Organization, cancer experts specially appointed by The Lancet, representatives of the First Affiliated Hospital of Huahuajia Medical University, and officials from the two committees and bureaus of Fengjing City.
More than 500 journalists were present, and they came from more than 100 countries, among which florist reporters accounted for more than 300 people.
The venue was crowded with people, squeezing and wiping.
The press conference was chaired by He Jinqiu, deputy general manager of Shiji Yeli Pharmaceutical Company.
He Jinqiu first introduced the recruitment of volunteers to reporters.
Then he said that as of 17:00 on the 17th, 95 of the 100 volunteers had arrived, and another volunteer was expected to arrive later, and the other four volunteers became ill and could not come before departure.
As far as he knows, three of the four have passed away in the past two days.
Another volunteer, who was unable to travel long distances, asked Yeri Pharmaceuticals
Applying to participate in remote clinical trials in the beautiful country, he will hire professionals to make a special trip to Fengjing to collect, deliver and inject the medicine for him.
He Jinqiu said that because of the cumbersome drug approval procedures in the beautiful country, the use of unapproved drugs is suspected of violating the local laws of the beautiful country, and the legal consequences are serious, so Yeli Pharmaceutical rejected the patient's request.
He expressed great regret for this.
At the same time, he also expressed the hope that this volunteer can recover as soon as possible and go to Fengjing for treatment as soon as possible. Yeli Pharmaceuticals can make an exception and reserve a place for him to participate in clinical trials at any time, with an indefinite period.
He Jinqiu said that the 4 vacant places have been filled by 4 flower grower volunteers in Fengjing, and the number of patients participating in the open clinical trial this time is still 100.
Tomorrow morning, these 100 volunteers will be admitted to a special ward prepared for them by the Affiliated Hospital of the Medical University, where they will receive concentrated treatment. In addition to exclusive doctors and nurses, only WHO experts, two ministries and commissions of flower growers and Experts from some world-renowned medical institutions entered to conduct supervision and inspection.
No journalists are allowed inside.
Yeli Pharmaceuticals will release relevant news during the trial in this hall at 18:00 every day.
He also said that after the press conference, Yeli Pharmaceuticals will publish the past medical records of 100 volunteers and various inspection results and imaging data before the trial on the company's official website, so that reporters can compare the next treatment effect.
After He Jinqiu finished speaking, the representative of WHO also made a brief speech.
The expert stated that they will abide by the three principles of fairness, impartiality and openness, seek truth from facts, strictly perform their duties, and participate in and supervise this public trial throughout the process, and evaluate the curative effect of cancer therapy in the most scientific way.
He also said that the WHO will also report to the reporters present in this hall after 18:00 every day what they have seen and heard and the problems and deficiencies discovered during the monitoring process.
To put it bluntly, what he meant was to find fault.
Afterwards, the representative of the competent department of the florists also spoke a few words.
The two ministries and commissions will also participate in this open clinical trial, and strictly follow the relevant regulations to supervise and guide the clinical trial. They will also coordinate with various departments to ensure that the clinical trial can be carried out smoothly and objectively.
Finally, it was time for reporters to ask questions.